Current Gene Therapy

Last updated

Content

Current Gene Therapy is a peer-reviewed journal published bi-monthly by Bentham Science. The journal content is aimed at academic and industrial scientists with technical focus on gene and cell therapy, preclinical and clinical research. The journal publishes articles concerning basic research and clinical applications of gene and cell therapy of diseases including new scientific methods, gene delivery systems, gene therapy treatments, as well as approaches to genetic modification with the aim of treating disease. A more recent focus of the journal includes Cell Therapy, with genetic modification, in essence ex vivo gene therapy. Previous issues have focused on the latest developments in gene transfer, gene expression and regulation, development of novel gene delivery vectors, and ex vivo gene therapies, animal models, and human therapeutic applications.

The journal publishes both full-length and mini-reviews, original research, meta-analysis, and results from clinical studies. In addition, the journal has published manuscripts focused on ethical and regulatory considerations of gene and cell therapy. As well as important regulatory, manufacturing, and logistical aspects of gene therapy research. The journal's review articles are aimed at providing background on "late breaking discoveries on which substantial literature has not yet been amassed".

History

The journal's first issue was published in 2001, making Current Gene Therapy one of the oldest peer-reviewed journals with a specific focus on Gene Therapy. The original issue focused on viral vectors for gene delivery vectors and use of gene therapy treatments for oncology. Current Gene Therapy was among the first gene therapy focused journals to publish on the use of Alphaviruses for gene therapy [2] , oncolytic virotherapy using adenoviral-mediated gene transfer [3] , and the use of Fas Ligand, TRAIL, and Bax for the treatment of prostate cancer. [4]

Abstracting and indexing

The journal is indexed in several citation and bibliographic databases with a focus on life sciences, biomedical research, and medicine: [5] [6]

According to Bioxbio the Academic Accelerator, the 2022-2023 journal impact factor is 4.676 and the real-time impact factor is 5.7. [7]

Related Research Articles

<span class="mw-page-title-main">Gene therapy</span> Medical field

Gene therapy is a medical technology which aims to produce a therapeutic effect through the manipulation of gene expression or through altering the biological properties of living cells.

<span class="mw-page-title-main">Tumor suppressor gene</span> Gene that inhibits expression of the tumorigenic phenotype

A tumor suppressor gene (TSG), or anti-oncogene, is a gene that regulates a cell during cell division and replication. If the cell grows uncontrollably, it will result in cancer. When a tumor suppressor gene is mutated, it results in a loss or reduction in its function. In combination with other genetic mutations, this could allow the cell to grow abnormally. The loss of function for these genes may be even more significant in the development of human cancers, compared to the activation of oncogenes.

Pyruvate dehydrogenase deficiency is a rare neurodegenerative disorder associated with abnormal mitochondrial metabolism. PDCD is a genetic disease resulting from mutations in one of the components of the pyruvate dehydrogenase complex (PDC). The PDC is a multi-enzyme complex that plays a vital role as a key regulatory step in the central pathways of energy metabolism in the mitochondria. The disorder shows heterogeneous characteristics in both clinical presentation and biochemical abnormality.

<i>Antiviral Therapy</i> (journal) Academic journal

Antiviral Therapy is a peer-reviewed medical journal published by International Medical Press. It publishes primary papers and reviews on all aspects of the clinical development of antiviral drugs, including clinical trial results, drug resistance, viral diagnostics, drug safety, pharmacoepidemiology, and vaccines. Antiviral Therapy is an official publication of the International Society for Antiviral Research.

Clinical and Vaccine Immunology (CVI) was a peer-reviewed journal published by the American Society for Microbiology. CVI enhances our understanding of the immune response in health and disease by showcasing important clinically relevant research, including new animal models for human immunologic diseases, viral immunology, immunopathogenesis, and clinical laboratory immunology. In particular, the journal highlights important discoveries in immunization and vaccine research, such as the development and evaluation of vaccines, human and animal immune responses to vaccines, vaccine vectors, adjuvants and immunomodulators, quantitative assays of vaccine efficacy, and clinical trials. The journal publishes primary research articles, editorials, commentaries, minireviews, and case reports. Articles are freely accessible after six months. Through its "Global Outreach Program", free online access is available to qualified microbiologists in eligible developing countries.

<i>Bone Marrow Transplantation</i> (journal) Peer-reviewed medical journal published by Nature Research

Bone Marrow Transplantation is a peer-reviewed medical journal covering transplantation of bone marrow in humans. It is published monthly by Nature Research. The scope of the journal includes stem cell biology, transplantation immunology, translational research, and clinical results of specific transplant protocols.

<i>Journal of Receptors and Signal Transduction</i> Academic journal

The Journal of Receptors and Signal Transduction is a peer-reviewed scientific journal that publishes laboratory and clinical studies, reviews, and brief communications on biological receptors and associated signal transduction pathways for ligands involved in the regulation of central and peripheral tissues and cells. It is published by Informa. The editors in chief are Alex N. Eberle and Terrence Kenakin.

Genes to Cells is a peer-reviewed scientific journal that publishes original research on the molecular mechanisms of biological events. The journal has been published since 1996 by Wiley-Blackwell on behalf of the Molecular Biology Society of Japan.

<i>Brain Injury</i> (journal) Academic journal

Brain Injury is a monthly, peer-reviewed, medical journal published by Taylor & Francis. Furthermore, it is the official journal of the International Brain Injury Association (IBIA). The chief editors are Jeffrey Kreutzer and Nathan Zasler.

<i>Cytotherapy</i> (journal) Academic journal

Cytotherapy is a peer-reviewed medical journal covering the areas of cell and gene therapy. The journal was established in 1999 and the Senior Editor is Donald G. Phinney. It is published by Elsevier on behalf of the International Society for Cell & Gene Therapy (ISCT).

<i>Physiotherapy: Theory and Practice</i> Academic journal

Physiotherapy: Theory and Practice is a peer-reviewed medical journal covering research in physiotherapy. It is published 8 times a year by Informa. The journal was established in 1985 and the editor-in-chief is Scott Hasson.

<i>Mechanisms of Development</i> Academic journal

Mechanisms of Development is a peer-reviewed scientific journal covering all aspects of developmental biology. It is the official journal of the International Society of Developmental Biologists and is published by Elsevier. The journal was established in 1972 as Cell Differentiation and was renamed Cell Differentiation and Development in 1988. It acquired its current name in December 1990. The editor-in-chief is D. Wilkinson. A separate section of the journal, Gene Expression Patterns, covers research on cloning and gene expression. In 2020 the journal became Cells & Development with the subtitle: 'Cell and Developmental Biology and their Quantitative Approaches'.

Neural Regeneration Research is a peer-reviewed scientific journal covering research on neuroregeneration and stem cells. Topics covered include neural stem cells, neural tissue engineering, gene therapy, and minimally-invasive treatment of neurodegenerative diseases. It was established in 2006 and the editors in chief are Kwok-Fai So and Xiao-Ming Xu. The journal publishes the following types of papers: research and reports, techniques and methods, investigation and analysis, meta-analyses and reviews, evidence-based case reports, and perspectives.

<i>Current HIV Research</i> Academic journal

Current HIV Research is a peer-reviewed scientific journal focusing on HIV/AIDS research, established in 2003. The journal is edited by Yuntao Wu and is published by Bentham Science Publishers. It has an impact factor of 1.581

Current Alzheimer Research is a peer-reviewed medical journal covering the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer's disease.

<span class="mw-page-title-main">Vectors in gene therapy</span>

Gene therapy utilizes the delivery of DNA into cells, which can be accomplished by several methods, summarized below. The two major classes of methods are those that use recombinant viruses and those that use naked DNA or DNA complexes.

Drugs & Aging is a monthly peer-reviewed medical journal published by Springer Nature under their Adis International imprint. It contains primarily review articles covering optimum use of drug therapies in older adults.

Gene therapy for osteoarthritis is the application of gene therapy to treat osteoarthritis (OA). Unlike pharmacological treatments which are administered locally or systemically as a series of interventions, gene therapy aims to establish sustained therapeutic effect after a single, local injection.

<i>Expert Review of Anti-infective Therapy</i> Academic journal

Expert Review of Anti-infective Therapy is a monthly peer-reviewed medical journal publishing review articles and original papers on all aspects of anti-infective therapy. The journal was established in 2003 and is published by Informa.

Current Drug Metabolism is a peer-reviewed medical journal covering the study of drug metabolism. It was established in 2000 and is published 10 times per year by Bentham Science Publishers. The editor-in-chief is Ming Hu. According to the Journal Citation Reports, the journal has a 2019 impact factor of 2.960.

References

  1. "Journal Home Page". Journal Home page. Archived from the original on 2015-10-06. Retrieved 2021-06-14.
  2. Lundstrom, K. (May 2001). "Alphavirus vectors for gene therapy applications". Current Gene Therapy. 1 (1): 19–29. doi:10.2174/1566523013349039. ISSN   1566-5232. PMID   12109136.
  3. Wu, Q.; Moyana, T.; Xiang, J. (May 2001). "Cancer gene therapy by adenovirus-mediated gene transfer". Current Gene Therapy. 1 (1): 101–122. doi:10.2174/1566523013349002. ISSN   1566-5232. PMID   12109134.
  4. Norris, J. S.; Hyer, M. L.; Voelkel-Johnson, C.; Lowe, S. L.; Rubinchik, S.; Dong, J. Y. (May 2001). "The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer". Current Gene Therapy. 1 (1): 123–136. doi:10.2174/1566523013348977. ISSN   1566-5232. PMID   12109135.
  5. "List of indexing services". Current Gene Therapy. Bentham Science Publishers. June 2021. Archived from the original on 2011-09-03. Retrieved 2021-06-14.
  6. "Current Gene Therapy". Chemical Abstracts Service . American Chemical Society. August 2011.{{cite web}}: Missing or empty |url= (help)
  7. "Current Gene Therapy Impact Factor IF 2023|2022|2021 - BioxBio". www.bioxbio.com. Retrieved 2023-11-23.